Mechanism of glutathione production in neurons].

Nobuko Matsumura, Chisato Kinoshita, Koji Aoyama

Nihon yakurigaku zasshi. Folia pharmacologica Japonica 2021

filter terms:

Glutathione (GSH) is a tripeptide consisting of glutamate, cysteine, and glycine that acts as an important neuroprotective molecule in the central nervous system. In neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, GSH levels in the brain would be decreased before the onset, and GSH dysregulation is considered to be involved in the development of these neurodegenerative diseases. Cysteine uptake into neurons is the rate-limiting step for GSH synthesis. Excitatory amino acid carrier 1 (EAAC1), which is a glutamate/cysteine cotransporter, is responsible for the neuronal cysteine uptake, and EAAC1 dysfunction reduces GSH levels in the brain and has a significant influence on the process of neurodegeneration. Since miR-96-5p, which is one of microRNAs, suppresses EAAC1 expression, it is conceivable that miR-96-5p inhibitor suppresses the onset or slows the progression of neurodegenerative diseases by increasing EAAC1 levels leading to promoting neuronal GSH production.

Citation

Nobuko Matsumura, Chisato Kinoshita, Koji Aoyama. Mechanism of glutathione production in neurons]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 2021;156(1):26-30